Hoimes, C. J., Albany, C., Hoffman-Censits, J., Fleming, M. T., Trabulsi, E., Picus, J., … Kaimakliotis, H. (2018). A phase Ib/II study of neoadjuvant pembrolizumab (pembro) and chemotherapy for locally advanced urothelial cancer (UC). Annals of Oncology : Official Journal of the European Society for Medical Oncology, 29, viii726. https://doi.org/10.1093/annonc/mdy424.039

Hoimes, C. J., C. Albany, J. Hoffman-Censits, M. T. Fleming, E. Trabulsi, J. Picus, C. Cary, et al. “A phase Ib/II study of neoadjuvant pembrolizumab (pembro) and chemotherapy for locally advanced urothelial cancer (UC).” Annals of Oncology : Official Journal of the European Society for Medical Oncology 29 (October 1, 2018): viii726. https://doi.org/10.1093/annonc/mdy424.039.

Hoimes CJ, Albany C, Hoffman-Censits J, Fleming MT, Trabulsi E, Picus J, et al. A phase Ib/II study of neoadjuvant pembrolizumab (pembro) and chemotherapy for locally advanced urothelial cancer (UC). Annals of oncology : official journal of the European Society for Medical Oncology. 2018 Oct 1;29:viii726.

Hoimes, C. J., et al. “A phase Ib/II study of neoadjuvant pembrolizumab (pembro) and chemotherapy for locally advanced urothelial cancer (UC).” Annals of Oncology : Official Journal of the European Society for Medical Oncology, vol. 29, Oct. 2018, p. viii726. Scopus, doi:10.1093/annonc/mdy424.039.

Hoimes CJ, Albany C, Hoffman-Censits J, Fleming MT, Trabulsi E, Picus J, Cary C, Koch MO, Walling R, Kelly W, Godwin JL, Cooney M, Fu P, Nelson A, Patel K, Eitman C, Breen T, Neal A, Kaimakliotis H. A phase Ib/II study of neoadjuvant pembrolizumab (pembro) and chemotherapy for locally advanced urothelial cancer (UC). Annals of oncology : official journal of the European Society for Medical Oncology. 2018 Oct 1;29:viii726.